Unified Women's Healthcare’s Post

We are excited to launch a new educational series where Dr. Kevin Kearney directly addresses critical health and wellness questions, with a focus on breast health. Our aim is to deepen understanding and foster dialogue within the medical community. 🌟 In our first episode: Dr. Kearney showcases the distinctive patient care approach at MD Breast Imaging. Unlike typical imaging centers, we ensure that every patient has the chance to sit down with Dr. Kearney post-screening. This direct interaction allows for immediate discussion of results, concerns, and next steps, reinforcing our commitment to patient-centered care. This personalized approach is uncommon but vital in the imaging world and is a standard practice at MD Breast Imaging. We believe effective healthcare is built on conversations, not just diagnostic reports. 👀 Watch the premiere episode now and stay tuned for more insightful sessions in the 'Behind the Screen with Dr. Kevin Kearney' series. We're dedicated to enhancing professional understanding and patient care through open dialogue and expert insights. 📩 We encourage your questions and engagement—comment below or send us a direct message with topics or questions you'd like us to explore in future episodes. #HealthcareEducation #BreastHealth #MedicalImaging #PhysicianLearning #MDBreastImaging

Last week, the 8th Edition of the Duchenne Patient Academy, a global platform empowering patient advocates in the Duchenne and Becker muscular dystrophy community, took place. The academy exemplifies how collaboration and education can drive and support meaningful change in rare diseases. Over two impactful days, patient advocates, researchers, and industry leaders shared insights on the latest in science, policy, and advocacy strategies related to Duchenne or Becker muscular dystrophy. Our Patient Advocacy lead had the opportunity to highlight our commitment to advancing therapies in the rare disease space and supporting the muscular dystrophy community. Sponsoring and engaging in initiatives like the Duchenne Patient Academy strengthens our connection with the community and amplifies our mission to improve the lives of patients and caregivers worldwide. Together, we’re making strides in turning hope into action for those affected by rare diseases. #RareDiseases #PatientAdvocacy #Italfarmaco #DMD

We use The Treehouse Vision System®, our proprietary clinical protocol, to slow the progression of myopia in children. The Treehouse Vision System® has been proven effective. Studies show that 78% of children who undergo this treatment show no progression in their myopia within the first year. That's a significant advantage for your patient's long-term eye health. Learn more about our unique partnership model offering our clinical protocol and resources, implementation playbook, demand generation, and more: https://lnkd.in/eE3Vtb-Y #myopia #myopiamanagement #optometrist

In the 4th episode we talk about innovative ways to focus on women’s health using “holistic preventive strategies” from our primary care physicians. It’s time we change the paradigm. #mammoheart #myadesso #heartcareisselfcare

🌍 Exciting insights from a recent article by Katie Quirk from Optometry Australia! An interview with Nicole Carnt, who, like our chairwoman Juliette Vila Sinclair-Spence, is among the thirty contributors to the Global Alliance Against Acanthamoeba Keratitis White Paper. In this discussion, we delve into the significance of spreading awareness about Acanthamoeba Keratitis. ➡️ https://lnkd.in/exhtBGEj By sharing this white paper, we aim to educate and raise awareness among all stakeholders, fostering a common language for better understanding. Acanthamoeba Keratitis may be tricky to pronounce and navigate initially, but this white paper breaks it down into digestible perspectives—from patient experiences to biological insights, clinical applications, and regulatory viewpoints. Let’s work together to improve awareness and understanding of this significant issue! 💡 #Optometry #AcanthamoebaKeratitis #HealthcareEducation #PublicHealth #GlobalAllianceAgainstAK

How is AI revolutionizing early health detection for newborns. Let's find out! Punktum is leading the way with their innovative Diaper ID project, using AI to analyze baby stool and identify early signs of liver diseases. For Josua Ziegler, CEO and Co-Founder of punktum, this groundbreaking solution is just the beginning of how AI can reshape healthcare. By combining cutting-edge technology with a deep understanding of healthcare challenges, Punktum is making early disease detection more accessible and impactful for parents and healthcare providers alike. When innovation meets purpose, life-saving solutions emerge. If you’ve been inspired by AI’s role in healthcare or have seen firsthand how technology is transforming patient care, comment below and share your thoughts! 🎥 Explore how the Diaper ID project is changing newborn healthcare—watch the full video now on YouTube! https://lnkd.in/dNdaxmC7

🌍 Exciting insights from a recent article by Katie Quirk from Optometry Australia! An interview with Nicole Carnt, who like me, is one of the thirty contributors to the Global Alliance Against Acanthamoeba Keratitis White Paper, we explore the importance of disseminating knowledge about Acanthamoeba Keratitis. ➡️ https://lnkd.in/ecqCHk7N By sharing this white paper, we aim to educate and raise awareness among all stakeholders, fostering a common language for better understanding. Acanthamoeba Keratitis may be tricky to pronounce and navigate initially, but this white paper breaks it down into digestible perspectives—from patient experiences to biological insights, clinical applications, and regulatory viewpoints. Let’s work together to improve awareness and understanding of this significant issue! 💡 #Optometry #AcanthamoebaKeratitis #HealthcareEducation #PublicHealth #GlobalAllianceAgainstAK

Explore the multifaceted landscape of pediatric atopic dermatitis care with expert insights. Gain valuable insights into comparative analyses, key takeaways from recent research, and the role of ruxolitinib in enhancing patient outcomes. Explore the series: https://ow.ly/rVZO50RSBLB

Since our inception, Women as One has been dedicated to supporting women in cardiovascular clinical research. This year, we were honored to attend the Global Heart Hub roundtable to represent that mission. Global Heart Hub is an alliance of cardiovascular patient organizations. In April, they hosted a roundtable to address the issue of late, missed and misdiagnosed heart disease in women. Central to this is addressing the lack of women in clinical research at every level. Women are vastly underrepresented in clinical trial leadership, which hinders innovation and the ability to enroll women patients in trials. This is crucial if we want to accurately understand the outcomes of treatment options for women. As heart disease is the leading cause of death among women worldwide, we know something must change. So do the myriad organizations that gathered with us at Global Heart Hub to discuss actionable ideas for improving women’s heart health. Women cardiologists can join our Talent Directory to strengthen their professional opportunities in research: https://bit.ly/4byg8AS View the data: https://lnkd.in/eYPBugWN #HealthEquity #WomeninMedicine #CardiovascularHealth #WomensHeartHealth

#HIWM12DaysOfChristmas Day 7! Fran Ives shares her personal highlight of responding to calls from our stakeholders to trial Point of Care Ultrasound (POCUS), and using a human factors approach in the implementation. The aim of the project was to improve the diagnosis, treatment, and management of paediatric haemophilia patients with suspected joint bleeds. You can read about our POCUS project on pages 16-17 of our 2023/24 Impact Report here: https://lnkd.in/da3scQH7 Birmingham Women's and Children's NHS Foundation Trust Butterfly Network, Inc.